Bone Therapeutics to strategically focus on lead cell therapy product ALLOB

BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the cell therapy company addressing unmet medical needs in orthopedics and other diseases, today announces it is redefining its strategic priorities to concentrate specifically on the development of its most advanced clinical asset, the allogeneic cell therapy ...

Related Keywords

Mont Saint Guibert ,Waals Gewest ,Belgium ,China ,Paris ,France General ,France ,Chinese ,Anne Leselbaum ,Stefanos Theoharis ,Miguel Forte ,Anne Sophie Lebrun , ,Tony Ting ,Lieve Creten ,Euronext Brussels ,Bone Therapeutics ,Bone Therapeutic ,Chief Medical Officer ,Chief Operation Officer ,Bone Therapeutics Chinese ,